An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)
Clinical trial NCT06625411 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06625411
- Sponsor
- Viridian Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2026-02-12
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.